Bespak separates inhaled and nasal drug delivery business from Recipharm, creating a global CDMO focused on pulmonary and nasal inhalation devices.

Bespak confirms completion of its inhaled and nasal drug delivery business separation from Recipharm. The spin-out creates a leading global CDMO focused on drug-device combination products and drug delivery devices for pulmonary and nasal inhalation. Bespak, a leading supplier of pressurised Metered Dose Inhaler (pMDI) dosing valves and actuators, is focusing on the transition to low GWP pMDIs.